首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   28647篇
  免费   2779篇
  国内免费   2277篇
耳鼻咽喉   230篇
儿科学   313篇
妇产科学   319篇
基础医学   3718篇
口腔科学   476篇
临床医学   3901篇
内科学   4601篇
皮肤病学   261篇
神经病学   1471篇
特种医学   1028篇
外国民族医学   21篇
外科学   2952篇
综合类   4529篇
现状与发展   9篇
一般理论   4篇
预防医学   1750篇
眼科学   718篇
药学   2895篇
  34篇
中国医学   1521篇
肿瘤学   2952篇
  2024年   110篇
  2023年   500篇
  2022年   1299篇
  2021年   1671篇
  2020年   1246篇
  2019年   982篇
  2018年   1088篇
  2017年   930篇
  2016年   886篇
  2015年   1395篇
  2014年   1707篇
  2013年   1347篇
  2012年   2033篇
  2011年   2278篇
  2010年   1380篇
  2009年   1097篇
  2008年   1409篇
  2007年   1487篇
  2006年   1408篇
  2005年   1535篇
  2004年   908篇
  2003年   807篇
  2002年   755篇
  2001年   624篇
  2000年   623篇
  1999年   693篇
  1998年   525篇
  1997年   475篇
  1996年   398篇
  1995年   363篇
  1994年   286篇
  1993年   165篇
  1992年   228篇
  1991年   170篇
  1990年   148篇
  1989年   138篇
  1988年   154篇
  1987年   104篇
  1986年   98篇
  1985年   71篇
  1984年   41篇
  1983年   34篇
  1982年   28篇
  1981年   21篇
  1980年   10篇
  1979年   18篇
  1978年   5篇
  1975年   3篇
  1971年   5篇
  1969年   5篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
The nucleocapsid (N) protein of SARS-coronavirus (SARS-CoV) is the key protein for the formation of the helical nucleocapsid during virion assembly. This protein is believed to be more conserved than other proteins of the virus, such as spike and membrane glycoprotein. In this study, the N protein of SARS-CoV was expressed in Escherichia coli DHSalpha and identified with pooled sera from patients in the convalescence phase of SARS. A plasmid pCI-N, encoding the full-length N gene of SARS-CoV, was constructed. Expression of the N protein was observed in COS1 cells following transfection with pCI-N. The immune responses induced by intramuscular immunization with pCI-N were evaluated in a murine model. Serum anti-N immunoglobutins and splenocytes proliferative responses against N protein were observed in immunized BALB/c mice. The major immunoglobulin G subclass recognizing N protein was immunoglobulin G2a, and stimulated splenocytes secreted high levels of gamma interferon and IL-2 in response to N protein. More importantly, the immunized mice produced strong delayed-type hypersensitivity (DTH) and CD^8+ CTL responses to N protein.  相似文献   
92.
浅析医疗机构中志愿者体系的管理和发展   总被引:8,自引:0,他引:8  
医疗志愿者体系发展至今,在国外已有相当的规模和管理机制,但是对于国内的医疗机构来说,仍在不断的探索中。本文将结合复旦大学附属儿科医院于2002年6月1日成立的首批“阳光爱心”志愿者队伍的情况,探究志愿者体系在医疗机构中的管理和发展。  相似文献   
93.
Multiple nerve blocks may be painful and a source of discomfort. We assessed the efficacy of sufentanil 5 microg combined with midazolam 1 mg in decreasing pain in outpatients after a midhumeral multiple nerve stimulation technique. Visual analog scores for pain were significantly lower in those patients who received sedation before the block, both at the time of block performance (14 +/- 1 vs 27 +/- 2 mm, P < 0.0001) and at discharge (11 +/- 1 vs 24 +/- 2 mm, P < 0. 0001). We conclude that the association of sufentanil and midazolam produced minimal sedation while significantly reducing pain experienced by patients undergoing multiple nerve stimulation.  相似文献   
94.
中医疾病证候学研究方法初探   总被引:1,自引:0,他引:1  
此次调查在西医辨病的基础上,以中医辨证理论方法为核心,按照事先设计的方案,收集特定时间内膝关节骨关节炎患者的病状,先进行计量诊断确立辨证要素,再进行聚类分析及logistic回归分析等筛选出特异性较高的症状,为疾病辨证分型、辨证标准的阐明提供依据.是一种值得介绍的中医证候研究方法.  相似文献   
95.
《中医杂志》1991年第2期薄震东、孙建中的《“弦滑”脉之管见》(以下简称《管见》),与2000年第9期傅文胜的《脉弦滑质疑》(以下简称《质疑》),从不同角度论述了相同的观点:弦、滑脉不能相兼。细阅两文,笔者发现两文中颇多错讹之处。两文作者对弦、滑两种脉象都尚未了解清楚。王叔和说脉诊是“在心易了,指下难明。”倘若在心还尚未“了”,指下又岂能“明”?为免贻误后学,不能不就弦、滑脉象作进一步辨析。  相似文献   
96.
认知是指人脑为获取和应用知识,将外界信息转化成内在心理活动的复杂过程。自 1998年Schmahmann和Sherman提出“小脑认知-情感综合征”起,小脑认知功能的研究越来越受到关注。 本文通过回顾国内外相关研究,从小脑的解剖与认知功能、小脑的神经网络机制以及交叉性小脑神经 机能联系不能 3 个角度探讨了小脑在认知神经网络中的作用及机制,旨在提高对小脑参与认知功能的 认识。  相似文献   
97.
[目的]评价股骨近端髓内钉(PFNA)与动力髋螺钉(DHS)在股骨粗隆骨折治疗中的临床疗效.[方法]将应用PFNA(39例)与DHS(36例)治疗的75例患者,从术中情况、术后并发症以及术后髋关节功能的恢复情况对两种治疗方法的临床疗效进行比较分析.[结果]DHS的手术失血量高于PFNA(P<0.05),同时其术后并发症也较PFNA明显增多(P<0.05),髋关节功能Harris评分优秀率也低于PFNA治疗组(P<0.05).[结论]PFNA在治疗上较DHS具有操作简单、创伤小、骨折固定牢固、并发症少及术后患者可早期离床负重等优点,是一种治疗股骨粗隆间骨折的理想方法,值得临床推广使用.  相似文献   
98.
ObjectiveTo analyze the use of packed red blood cells (PRBCs) for patients with pelvic fracture and evaluate factors associated with PRBC transfusion for patients with pelvic fracture.MethodsThis retrospective cohort study collected 551 patients with pelvic fractures from six hospitals between September 1, 2012, and June 31, 2019. The age span of patients varied from 10 to 95 years old, and they were classified into two groups based on high‐energy pelvic fractures (HE‐PFs) or low‐energy pelvic fractures (LE‐PFs). The study''s outcome was the use of PRBCs, fresh frozen plasma (FFP), and albumin. Demographic data, characteristics, laboratory tests, clinical treatment details, and clinical outcomes were compared between the two groups. Factors that were statistically associated with perioperative PRBCs in univariate analyses were included to conduct an optimal scale regression to determine the independent factors for perioperative PRBCs.ResultsA total of 551 patients were screened from six hospitals, and after inclusion and exclusion, 319 were finally included and finished the follow‐up from admission to discharge, while four patients died during hospitalization. Three hundred and nineteen patients were classified into two groups by their injury mechanisms. A total of 230/319 (72.1%) patients were classified into the HE‐PF group, and 89/319 (27.8%) patients were classified into the LE‐PF group. Patients in the HE‐PF group were transfused with 4.5 (3–8) units of PRBCs, 300 (0–600) ml of FFP, and 0 (0–30) g of albumin, while patients in the LE‐PF group were transfused with 3.5 (2–4.5) units of PRBCs, 0 (0–295) ml of FFP, and 0 (0–0) g of albumin (all P < 0.001). There were higher proportions of male patients and patients under 65 in the HE‐PF group (all P < 0.001). HE‐PF group patients were more severely injured and likely to take external fixation. The optimal scale regression revealed four significant factors associated with perioperative transfused PRBCs, which were patients on admission with hemorrhagic shock (importance = 0.283, P = 0.004), followed by fracture types identified by Tile classification (importance = 0.156, P < 0.001), hemoglobin levels below 70 g/L on admission (importance = 0.283, P = 0.004), followed by fracture types identified by Tile classification (importance = 0.156, P < 0.001), hemoglobin levels below 70 g/L on admission (importance = 0.148, P = 0.039), and methods of pelvic fixation (importance = 0.008, P = 0.026), ranked by the importance.ConclusionPatients with HE‐PFs had increased transfusions of PRBCs, FFP, and albumin, and hemorrhagic shock on admission, Tile classification, Hb levels, and stabilization methods were found to be associated with perioperative PRBCs.  相似文献   
99.
目的 比较腓骨髓内钉与切开复位钉板系统治疗腓骨远端骨折的疗效.方法 回顾性分析2017年10月至2019年10月于锦州医科大学附属第一医院采用手术治疗腓骨骨折的患者,按照纳入、排除标准筛选病例,最终A组髓内钉组25例纳入研究、B组钉板内固定组35例纳入研究.比较两组入院至行腓骨手术的时间,手术时长,腓骨术口总长度,AO...  相似文献   
100.
Adenoviruses can cause infections in people of all ages at all seasons of the year. Adenovirus infections cause mild to severe illnesses. Children, immunocompromised patients, or those with existing respiratory or cardiac disease are at higher risk. Unfortunately, there are no commercial drugs or vaccines available on the market for adenovirus infections. Therefore, there is an urgent need to discover new antiviral drugs or drug targets for adenovirus infections. To identify potential antiviral agents for adenovirus infections, we screened a drug library containing 2138 compounds, most of which are drugs with known targets and past phase I clinical trials. On a cell-based assay, we identified 131 hits that inhibit adenoviruses type 3 and 5. A secondary screen confirmed the antiviral effects of 59 inhibitors that inhibit the replication of adenoviruses type 3 or 5. Most of the inhibitors target heat shock protein, protein tyrosine kinase, the mTOR signaling pathway, and other host factors, suggesting that these host factors may be essential for replicating adenoviruses. Through this study, the newly identified adenovirus inhibitors may provide a start point for developing new antiviral drugs to treat adenovirus infections. Further validation of the identified drug targets can help the development of new therapeutics against adenovirus infections.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号